Riska, M., H. Haryati, E. Suhartono, and T. A. . Wanahari. “Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated With Tyrosine Kinase Inhibitors”. Jurnal Respirasi, vol. 8, no. 3, Sept. 2022, pp. 133-9, doi:10.20473/jr.v8-I.3.2022.133-139.